Dormant Viruses Wake Up: Epstein-Barr, Shingles and the Link to Long Covid Explored

Podcast overview

NPR's Short Wave explores how dormant herpesviruses linger in most adults and how immune stress can awaken them. Yale immunologist Akiko Iwasaki explains how viruses such as Epstein Barr and varicella zoster can reactivate under stress, aging, or co infections, and how this may relate to long Covid.

• Key concept: latency and reactivation of herpesviruses
• Earthbound stressors can trigger multiple viruses at once
• Connections to long Covid and possible treatment paths
• Need for antivirals targeting latent viruses

Explaining latency and reactivation

The podcast centers on the idea that many familiar viruses, especially herpesviruses, can hide in the body in a latent state. They can wake up when the immune system is stressed by factors like infection, aging, or physical or mental strain. Akiko Iwasaki from Yale School of Medicine explains that in astronauts, the stressors of space flight caused reactivation of viruses such as Epstein Barr and cytomegalovirus in more than half of those tested. The discussion emphasizes that multiple dormant viruses can reactivate in the same person, highlighting the importance of the immune system in keeping these viruses dormant and the potential public health implications if such reactivations are occurring more broadly on Earth.

Dormant viruses and long Covid connection

The host describes how recent research links herpesviruses to long Covid. Epstein Barr virus, previously associated with mononucleosis and multiple sclerosis, may reactivate in some individuals after a SARS CoV 2 infection, potentially driving inflammatory processes or autoimmune phenomena that contribute to persistent symptoms. The conversation also touches on the possibility that ongoing SARS CoV 2 infection and autoimmunity may intersect with herpesvirus reactivation, creating a domino effect that complicates treatment. The episode underscores the need for deeper research into who is at risk for these mechanisms and how to intercept them with antiviral strategies or targeted therapies.

Implications for vaccines and antiviral strategies

The experts discuss how understanding viral latency could inform the development of vaccines or antivirals that specifically target latent viruses. While vaccines exist for chickenpox and shingles, vaccines for other herpesviruses remain an area of interest. The conversation also notes that existing antivirals may be insufficient for latent infections, and that stronger tools could help prevent reactivation and the associated health burdens.

Open questions and future directions

The episode closes by outlining critical questions for future research. How exactly does stress influence viral reactivation? Which patients are most at risk for herpesvirus driven long Covid or autoimmune sequelae? Can clinicians identify the domino pieces that have fallen in a given patient and tailor treatments accordingly? The host then invites listeners to follow ongoing research into long Covid, dormant viruses, and antiviral development.